CAMBRIDGE, MA--(Marketwired - November 10, 2016) - Exosome Diagnostics, Inc. in recent partnership with Takeda Pharmaceuticals has produced the industry's first data demonstrating the power of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, the developer of the leading liquid biopsy platform that enables non-invasive diagnosis of disease states, aiming to obviate the need for tissue ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, Inc. presented data that sets a new standard for EGFR-T790M resistance mutation detection in lung cancer, with the highest sensitivity reported ...
Exosome Diagnostics, Inc., a market leader in liquid biopsy and the world’s first exosome-based diagnostics company announces a collaboration agreement with Intezyne, Inc. to design and validate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results